OMKAR PHARMACHEM [OMKARPH] vs Innova Captab [INNOVACAP] Detailed Stock Comparison

OMKAR PHARMACHEM LTD.

BSE
Loading...

Innova Captab Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: OMKAR PHARMACHEM LTD. wins in 6 metrics, Innova Captab Ltd. wins in 11 metrics, with 1 ties. Innova Captab Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric OMKAR PHARMACHEM LTD. Innova Captab Ltd. Better
P/E Ratio (TTM) 327.78 31.20 Innova Captab Ltd.
Price-to-Book Ratio 3.13 4.05 OMKAR PHARMACHEM LTD.
Debt-to-Equity Ratio 0.00 32.95 Tie
PEG Ratio -5.03 1.33 Innova Captab Ltd.
EV/EBITDA 140.88 20.49 Innova Captab Ltd.
Profit Margin (TTM) 16.73% 8.85% OMKAR PHARMACHEM LTD.
Operating Margin (TTM) 37.71% 12.88% OMKAR PHARMACHEM LTD.
EBITDA Margin (TTM) 37.71% 12.88% OMKAR PHARMACHEM LTD.
Return on Equity 2.13% 13.37% Innova Captab Ltd.
Return on Assets (TTM) 2.09% 8.12% Innova Captab Ltd.
Free Cash Flow (TTM) $2.40M $-1.09B OMKAR PHARMACHEM LTD.
Dividend Yield N/A 0.30% N/A
1-Year Return -3.09% -3.19% OMKAR PHARMACHEM LTD.
Price-to-Sales Ratio (TTM) 58.34 2.76 Innova Captab Ltd.
Enterprise Value $296.42M $43.41B Innova Captab Ltd.
EV/Revenue Ratio 58.12 2.90 Innova Captab Ltd.
Gross Profit Margin (TTM) N/A 35.19% N/A
Revenue per Share (TTM) $1 $262 Innova Captab Ltd.
Earnings per Share (Diluted) $0.09 $23.16 Innova Captab Ltd.
Beta (Stock Volatility) 0.10 -0.33 Innova Captab Ltd.

OMKAR PHARMACHEM LTD. vs Innova Captab Ltd. Stock Performance Analysis

Loading Price Chart...

OMKARPH
INNOVACAP

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
OMKAR PHARMACHEM LTD.-4.99%-5.00%-8.49%-13.05%-9.46%-13.75%
Innova Captab Ltd.-0.63%2.24%2.13%29.82%21.15%16.79%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
OMKAR PHARMACHEM LTD.-3.09%8.00%35.68%344.81%413.31%581.82%
Innova Captab Ltd.-3.19%57.07%57.07%57.07%57.07%57.07%

Performance & Financial Health Analysis: OMKAR PHARMACHEM LTD. vs Innova Captab Ltd.

MetricOMKARPHINNOVACAP
Market Information
Market Cap i₹297.55M₹41.43B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i4578,151
90 Day Avg. Volume i1217,693
Last Close₹24.37₹857.00
52 Week Range₹24.37 - ₹29.74₹622.00 - ₹1,020.70
% from 52W High-18.06%-16.04%
All-Time High₹30.09 (May 26, 2025)₹1,260.00 (Jan 06, 2025)
% from All-Time High-19.01%-31.98%
Growth Metrics
Quarterly Revenue Growth-0.22%0.42%
Quarterly Earnings Growth-0.65%0.23%
Financial Health
Profit Margin (TTM) i0.17%0.09%
Operating Margin (TTM) i0.38%0.13%
Return on Equity (TTM) i0.02%0.13%
Debt to Equity (MRQ) i0.0032.95
Cash & Liquidity
Book Value per Share (MRQ)₹9.44₹178.28
Cash per Share (MRQ)₹0.06₹10.22
Operating Cash Flow (TTM) i₹2.44M₹282.88M
Levered Free Cash Flow (TTM) i₹2.01M₹1.28B
Dividends
Last 12-Month Dividend Yield iN/A0.30%
Last 12-Month Dividend iN/A₹2.00

Valuation & Enterprise Metrics Analysis: OMKAR PHARMACHEM LTD. vs Innova Captab Ltd.

MetricOMKARPH (Apr 24, 2026)INNOVACAP (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i327.7831.20
Forward P/E iN/A21.90
PEG Ratio i-5.031.33
Price to Sales (TTM) i58.342.76
Price to Book (MRQ) i3.134.05
Market Capitalization
Market Capitalization i₹297.55M₹41.43B
Enterprise Value i₹296.42M₹43.41B
Enterprise Value Metrics
Enterprise to Revenue i58.122.90
Enterprise to EBITDA i140.8820.49
Risk & Other Metrics
Beta i0.10-0.33
Book Value per Share (MRQ) i₹9.44₹178.28

Financial Statements Comparison: OMKAR PHARMACHEM LTD. vs Innova Captab Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricOMKARPH (2025)INNOVACAP (2025)
Revenue/Sales i5.40M12.34B
Cost of Goods Sold i08.38B
COGS % of Revenue i0.0%67.9%
Gross Profit i5.40M3.96B
Gross Margin i100.0%32.1%
Research & Development iN/AN/A
Operating Income (EBIT) i2.86M1.65B
Operating Margin i53.0%13.4%
EBITDA i2.93M2.00B
EBITDA Margin i54.3%16.2%
Pre-Tax Income i2.70M1.71B
Pre-Tax Income % of Revenue i50.0%13.9%
Income Tax i691,000427.58M
Income Tax % of Revenue i12.8%3.5%
Net Income (Profit) i2.01M1.28B
Profit Margin i37.2%10.4%

Balance Sheet & Liquidity Metrics

MetricOMKARPH (2025)INNOVACAP (2025)
Cash & Equivalents i1.09M155.19M
Total Current Assets i2.65M7.03B
Total Current Assets % of Revenue i49.1%57.0%
Total Current Liabilities i1.70M3.53B
Total Current Liabilities % of Revenue i31.4%28.6%
Long-Term Debt i02.45B
Long-Term Debt % of Revenue i0.0%19.8%
Total Shareholders Equity i94.34M9.59B
Retained Earnings i-6.50M4.53B
Retained Earnings % of Revenue i-120.4%36.7%
Property, Plant & Equipment i183,000442.93M

Cash Flow Statement Comparison

MetricOMKARPH (2025)INNOVACAP (2025)
Operating Cash Flow i2.44M282.88M
Operating Cash Flow % of Revenue i45.2%2.3%
Capital Expenditures i-40,000-1.72B
Free Cash Flow i2.40M-1.09B
FCF Margin i44.4%-8.8%
Debt Repayment iN/A-114.03M
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricOMKARPHINNOVACAP
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i10.08M57.22M
Float Shares i4.97M15.91M
% Held by Insiders i51.14%72.19%
% Held by Institutions i0.00%19.22%
% Held by Public i48.86%8.59%

Dividend Analysis & Yield Comparison: OMKAR PHARMACHEM LTD. vs Innova Captab Ltd.

MetricOMKARPHINNOVACAP
Last 12-Month Dividend iN/A₹2.00
Last 12-Month Dividend Yield iN/A0.30%
3-Year Avg Annual Dividend iN/A₹0.67
3-Year Avg Dividend Yield iN/A0.30%
3-Year Total Dividends iN/A₹2.00
Ex-Dividend DateN/AJan 30, 2026